Hearing Aids and the Brain

March 23, 2023 updated by: VA Office of Research and Development
Hearing aids are being fit on inexperienced hearing aid users and the short-term and long-term effects are measured. This research aims to improve understanding of the individual factors that contribute to receiving benefit from hearing aids and lead to more individualized treatment of hearing loss.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

Hearing aids are used to improve audibility for patients with hearing loss and improve speech perception. In addition to these immediate benefits, amplification has the potential to have long-term effects on higher level auditory processing abilities, such as cognition or other abilities required for complex listening tasks. These long-term acclimatization effects are not well understood and merit further behavioral and physiological examination. Hearing aids will be fit on inexperienced hearing aid users and outcome measures will be used to determine immediate and long-term effects of hearing aids. This research may provide a more detailed view of individual differences that contribute to receiving benefit from a hearing aid and may lead to more individualized treatment of hearing loss.

Study Type

Interventional

Enrollment (Actual)

20

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Oregon
      • Portland, Oregon, United States, 97239
        • VA Portland Health Care System, Portland, OR

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

50 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • 50 years of age or older
  • Bilateral, mild to moderately severe hearing loss
  • Inexperienced hearing aid users

Exclusion Criteria:

  • Subject deciding that they do not wish to wear hearing aids as necessitated per study protocol
  • Audiometric thresholds that suggest research stimuli would not be audible
  • Conductive hearing loss and/or other significant ear or hearing problems
  • Non-native English speakers
  • Conditions or circumstances that would preclude a participant from wearing hearing aids consistently or finishing the study
  • An inability to perform or complete the experimental tasks

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Hearing aids
All study participants will be fit with hearing aids.
Subjects are fit with hearing aids.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Evoked potential latency
Time Frame: Approximately 1 year
Latency will be measured in milliseconds
Approximately 1 year
Evoked potential amplitude
Time Frame: Approximately 1 year
Amplitude will be measured in microvolts
Approximately 1 year
Frequency following response magnitude
Time Frame: Approximately 1 year
Magnitude of response measured in nanovolts
Approximately 1 year
Frequency following response timing
Time Frame: Approximately 1 year
Timing measured by cross-correlation between stimulus and response
Approximately 1 year
Ongoing electroencephalography power
Time Frame: Approximately 1 year
EEG power as a function of frequency recorded during words-in-noise measure
Approximately 1 year
Montreal Cognitive Assessment score
Time Frame: Approximately 1 year
Assessment score from 1 to 30
Approximately 1 year
Reading Span
Time Frame: Approximately 1 year
Percent correct recall on working memory task
Approximately 1 year
Hearing aid usage
Time Frame: Approximately 1 year
Data logging from the hearing aid will provide usage in hours per day
Approximately 1 year
Word-in-noise perception testing
Time Frame: Approximately 1 year
Signal-to-noise ratio at which participant correctly understands 50% of speech in noise using WIN test
Approximately 1 year
Listening invested/required effort
Time Frame: Approximately 1 year
Participants' rating of the effort required (0-9) and invested (0-9) for listening task
Approximately 1 year
Working memory testing
Time Frame: Approximately 1 year
Performance on auditory working memory task
Approximately 1 year
Glasgow Hearing Aid Benefit Profile (GHABP)
Time Frame: Approximately 1 year
Participants rating on five-point scale their perceived initial (i.e., unaided) hearing disability, initial handicap, aided benefit, aided handicap, HA use and HA satisfaction in four listening situations
Approximately 1 year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 22, 2018

Primary Completion (Actual)

January 31, 2021

Study Completion (Actual)

January 31, 2021

Study Registration Dates

First Submitted

August 23, 2017

First Submitted That Met QC Criteria

September 8, 2017

First Posted (Actual)

September 12, 2017

Study Record Updates

Last Update Posted (Actual)

March 24, 2023

Last Update Submitted That Met QC Criteria

March 23, 2023

Last Verified

March 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

Yes

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hearing Loss

Clinical Trials on hearing aids

3
Subscribe